These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28045974)

  • 61. Equine Herpesvirus-I Infection in Horses: Recent Updates on its Pathogenicity, Vaccination, and Preventive Management Strategies.
    Khusro A; Aarti C; Rivas-Caceres RR; Barbabosa-Pliego A
    J Equine Vet Sci; 2020 Apr; 87():102923. PubMed ID: 32172913
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge.
    Stokes A; Alber DG; Cameron RS; Marshall RN; Allen GP; Killington RA
    Virus Res; 1996 Oct; 44(2):97-109. PubMed ID: 8879139
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevention of Rhodococcus equi pneumonia of foals using two different inactivated vaccines.
    Varga J; Fodor L; Rusvai M; Soós I; Makrai L
    Vet Microbiol; 1997 Jun; 56(3-4):205-12. PubMed ID: 9226835
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epizootiological investigation of equine herpesvirus type 1 infection among Japanese racehorses before and after the replacement of an inactivated vaccine with a modified live vaccine.
    Bannai H; Tsujimura K; Nemoto M; Ohta M; Yamanaka T; Kokado H; Matsumura T
    BMC Vet Res; 2019 Aug; 15(1):280. PubMed ID: 31387602
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use of the meridian test for the detection of equine herpesvirus type 1 infection in horses with decreased performance.
    Chvala S; Nowotny N; Kotzab E; Cain M; van den Hoven R
    J Am Vet Med Assoc; 2004 Aug; 225(4):554-9. PubMed ID: 15344363
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
    Ellis JA; Bogdan JR; Kanara EW; Morley PS; Haines DM
    J Am Vet Med Assoc; 1995 Mar; 206(6):823-32. PubMed ID: 7538990
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Innate immune responses of airway epithelial cells to infection with equine herpesvirus-1.
    Soboll Hussey G; Ashton LV; Quintana AM; Lunn DP; Goehring LS; Annis K; Landolt G
    Vet Microbiol; 2014 May; 170(1-2):28-38. PubMed ID: 24560592
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Control of EHV-1 viremia and nasal shedding by commercial vaccines.
    Goehring LS; Wagner B; Bigbie R; Hussey SB; Rao S; Morley PS; Lunn DP
    Vaccine; 2010 Jul; 28(32):5203-11. PubMed ID: 20538091
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
    BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)--masters of co-evolution and a constant threat to equids and beyond.
    Ma G; Azab W; Osterrieder N
    Vet Microbiol; 2013 Nov; 167(1-2):123-34. PubMed ID: 23890672
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Low-dose ginseng (Panax quinquefolium) modulates the course and magnitude of the antibody response to vaccination against equid herpesvirus I in horses.
    Pearson W; Omar S; Clarke AF
    Can J Vet Res; 2007 Jul; 71(3):213-7. PubMed ID: 17695597
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
    Heldens JG; Hannant D; Cullinane AA; Prendergast MJ; Mumford JA; Nelly M; Kydd JH; Weststrate MW; van den Hoven R
    Vaccine; 2001 Jul; 19(30):4307-17. PubMed ID: 11457558
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997.
    Gilkerson JR; Whalley JM; Drummer HE; Studdert MJ; Love DN
    Vet Microbiol; 1999 Aug; 68(1-2):15-25. PubMed ID: 10501158
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Primary vaccination in foals: a comparison of the serological response to equine influenza and equine herpesvirus vaccines administered concurrently or 2 weeks apart.
    Allkofer A; Garvey M; Ryan E; Lyons R; Ryan M; Lukaseviciute G; Walsh C; Venner M; Cullinane A
    Arch Virol; 2021 Feb; 166(2):571-579. PubMed ID: 33410993
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immune responses of specific pathogen free foals to EHV-1 infection.
    Chong YC; Duffus WP
    Vet Microbiol; 1992 Oct; 32(3-4):215-28. PubMed ID: 1280876
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review.
    Patel JR; Heldens J
    Vet J; 2005 Jul; 170(1):14-23. PubMed ID: 15993786
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection of EHV-1 and EHV-4 DNA in unweaned Thoroughbred foals from vaccinated mares on a large stud farm.
    Foote CE; Love DN; Gilkerson JR; Whalley JM
    Equine Vet J; 2004 May; 36(4):341-5. PubMed ID: 15163042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW; Porter RC; Ford SJ
    Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
    [No Abstract]   [Full Text] [Related]  

  • 79. Detection of antibodies against equine herpesvirus types 1 and 4 by using recombinant protein derived from an immunodominant region of glycoprotein B.
    Sinclair R; Binns MM; Chirnside ED; Mumford JA
    J Clin Microbiol; 1993 Feb; 31(2):265-71. PubMed ID: 8381809
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.